- Generic name
- Palonosetron
- Strength
- .075 mg/1.5 ml
- Dosage form
- Injection
- Manufactured by
- Radiant Pharmaceuticals Ltd.
Oxipal 0.075 mg/1.5 ml IV Injection
About Oxipal 0.075 mg/1.5 ml IV Injection
Oxipal 0.075 mg/1.5 ml IV comes as a injection with.075 mg/1.5 ml of Palonosetron, from Radiant Pharmaceuticals Ltd. It may also be used for nausea and vomiting after surgery.
There are 16 brands of Palonosetron listed in Bangladesh.
What is Oxipal 0.075 mg/1.5 ml IV Injection?
Oxipal 0.075 mg/1.5 ml IV.075 mg/1.5 ml is a injection product of Radiant Pharmaceuticals Ltd. that contains Palonosetron. It is used for acute and delayed nausea and vomiting, including nausea and vomiting caused by chemotherapy or radiotherapy, and for uncontrolled nausea and vomiting. Oxipal 0.075 mg/1.5 ml IV is an injection that contains Palonosetron, a medicine from the anti-emetic group. The doctor decides whether it is suitable and how it should be taken.
Uses of Oxipal 0.075 mg/1.5 ml IV
It may also be used for nausea and vomiting after surgery. It is an anti-emetic medicine, meaning it acts against nausea and vomiting. It is also used for uncontrolled nausea and vomiting and for nausea and vomiting caused by chemotherapy or radiotherapy. Your doctor will decide if it is right for your situation.
How to use Oxipal 0.075 mg/1.5 ml IV
Oxipal 0.075 mg/1.5 ml IV is given as an injection by a doctor or nurse, usually into a vein. Oxipal 0.075 mg/1.5 ml IV is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Swallow the injection with a glass of water. Do not change the dose or stop early without asking your doctor. Always follow the instructions of your doctor or nurse.
Side effects of Oxipal 0.075 mg/1.5 ml IV
Your healthcare team can advise on what to do and whether any further care is needed. The most common side effects are headache and constipation. Not everyone who takes it will have these effects. Tell your doctor if any side effect bothers you or does not go away. Ask your doctor or pharmacist about anything unusual you notice after taking Oxipal 0.075 mg/1.5 ml IV, and seek medical help promptly if you have a severe reaction or any symptom that worries you.
Safety and precautions
Do not receive Oxipal 0.075 mg/1.5 ml IV if you are allergic to Palonosetron or any ingredient in the injection. If you are pregnant or breastfeeding, ask your doctor first; the medicine is in pregnancy category B, and it is not known if it passes into breast milk. Only the doctor can decide whether this injection is appropriate for you. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Oxipal 0.075 mg/1.5 ml IV treat?
It may also be used for nausea and vomiting after surgery. It is an anti-emetic medicine, meaning it acts against nausea and vomiting.
How should I take Oxipal 0.075 mg/1.5 ml IV?
Oxipal 0.075 mg/1.5 ml IV is given as an injection by a doctor or nurse, usually into a vein. Oxipal 0.075 mg/1.5 ml IV is given as an injection by a healthcare professional.
What are the side effects of Oxipal 0.075 mg/1.5 ml IV?
Your healthcare team can advise on what to do and whether any further care is needed. The most common side effects are headache and constipation.
Can I use Oxipal 0.075 mg/1.5 ml IV in pregnancy or while breastfeeding?
Do not receive Oxipal 0.075 mg/1.5 ml IV if you are allergic to Palonosetron or any ingredient in the injection. If you are pregnant or breastfeeding, ask your doctor first; the medicine is in pregnancy category B, and it is not known if it passes into breast milk.
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Pharmacology
Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
Dosage & Administration
Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Overdose Effects
Storage Conditions
Alternative brands of Palonosetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.